Weiguo Ye
CIK 1985496 · View on SEC EDGAR ↗
First SEC filing: June 15, 2026 · Latest: June 15, 2026
On this page
Insider at
Insider transactions
Price change vs current quote, split-adjusted for corporate actions since the filing — not benchmarked, not annualized, not size-weighted
| Date | Ticker | Code | Shares | Price | Value | Owned after | Δ own | A/D | vs now |
|---|---|---|---|---|---|---|---|---|---|
| June 18, 2026 | GYRE | S | 3,000 | $6.35 | $19,050 | 700,000 Direct | -0.43% | Disposed | 13.5% (price as of 2026-08-19) |
| June 11, 2026 | GYRE | S | 2,800 | $6.17 | $17,276 | 700,000 Direct | -0.40% | Disposed | 16.8% (price as of 2026-08-19) |
| June 10, 2026 | GYRE | S | 5,000 | $6.24 | $31,200 | 700,000 Direct | -0.71% | Disposed | 15.5% (price as of 2026-08-19) |
| June 10, 2026 | GYRE | S | 6,418 | $6.21 | $39,856 | 700,000 Direct | -0.91% | Disposed | 16.0% (price as of 2026-08-19) |
| June 9, 2026 | GYRE | S | 3,000 | $6.15 | $18,450 | 700,000 Direct | -0.43% | Disposed | 17.2% (price as of 2026-08-19) |
| June 9, 2026 | GYRE | S | 14,500 | $6.14 | $89,030 | 700,000 Direct | -2.03% | Disposed | 17.3% (price as of 2026-08-19) |
| June 5, 2026 | GYRE | S | 15,401 | $6.40 | $98,566 | 700,000 Direct | -2.15% | Disposed | 12.6% (price as of 2026-08-19) |
| June 4, 2026 | GYRE | S | 19,575 | $6.13 | $119,995 | 700,000 Direct | -2.72% | Disposed | 17.5% (price as of 2026-08-19) |
| May 26, 2026 | GYRE | S | 4,000 | $6.10 | $24,400 | 700,000 Direct | -0.57% | Disposed | 18.1% (price as of 2026-08-19) |
| May 22, 2026 | GYRE | S | 3,500 | $6.08 | $21,280 | 700,000 Direct | -0.50% | Disposed | 18.5% (price as of 2026-08-19) |
| May 21, 2026 | GYRE | S | 12,820 | $6.15 | $78,843 | 700,000 Direct | -1.80% | Disposed | 17.2% (price as of 2026-08-19) |
| May 20, 2026 | GYRE | S | 9,400 | $6.15 | $57,810 | 700,000 Direct | -1.33% | Disposed | 17.2% (price as of 2026-08-19) |
| May 19, 2026 | GYRE | S | 9,120 | $6.37 | $58,094 | 700,000 Direct | -1.29% | Disposed | 13.1% (price as of 2026-08-19) |
| May 18, 2026 | GYRE | S | 200 | $6.62 | $1,324 | 700,000 Direct | -0.03% | Disposed | 8.8% (price as of 2026-08-19) |
| May 15, 2026 | GYRE | S | 13,100 | $6.65 | $87,115 | 700,000 Direct | -1.84% | Disposed | 8.3% (price as of 2026-08-19) |
| May 14, 2026 | GYRE | S | 15,580 | $6.91 | $107,658 | 700,000 Direct | -2.18% | Disposed | 4.3% (price as of 2026-08-19) |
P = Open-market purchase · S = Sale · A = Grant/award · M = Option exercise · G = Gift · F = Tax withholding
Insider transactions are not a recommendation; sales are often driven by liquidity or tax reasons.
Derivative holdings (Form 4 Table II)
Options, RSUs and convertible securities reported on Form 4 Table II.
| Date | Ticker | Security | Underlying | Exercise price | Expiration | Shares | A/D |
|---|---|---|---|---|---|---|---|
| June 18, 2026 | GYRE | Stock Option (Right to Buy) | Common Stock (3,000) | $0.75 | Oct. 31, 2030 | 3,000 | Disposed |
| June 11, 2026 | GYRE | Stock Option (Right to Buy) | Common Stock (2,800) | $0.75 | Oct. 31, 2030 | 2,800 | Disposed |
| June 10, 2026 | GYRE | Stock Option (Right to Buy) | Common Stock (5,000) | $0.75 | Oct. 31, 2030 | 5,000 | Disposed |
| June 10, 2026 | GYRE | Stock Option (Right to Buy) | Common Stock (6,418) | $0.75 | Oct. 31, 2030 | 6,418 | Disposed |
| June 9, 2026 | GYRE | Stock Option (Right to Buy) | Common Stock (3,000) | $0.75 | Oct. 31, 2030 | 3,000 | Disposed |
| June 9, 2026 | GYRE | Stock Option (Right to Buy) | Common Stock (14,500) | $0.75 | Oct. 31, 2030 | 14,500 | Disposed |
| June 5, 2026 | GYRE | Stock Option (Right to Buy) | Common Stock (15,401) | $0.75 | Oct. 31, 2030 | 15,401 | Disposed |
| June 4, 2026 | GYRE | Stock Option (Right to Buy) | Common Stock (19,575) | $0.75 | Oct. 31, 2030 | 19,575 | Disposed |
| May 26, 2026 | GYRE | Stock Option (Right to Buy) | Common Stock (4,000) | $0.75 | Oct. 31, 2030 | 4,000 | Disposed |
| May 22, 2026 | GYRE | Stock Option (Right to Buy) | Common Stock (3,500) | $0.75 | Oct. 31, 2030 | 3,500 | Disposed |
| May 21, 2026 | GYRE | Stock Option (Right to Buy) | Common Stock (12,820) | $0.75 | Oct. 31, 2030 | 12,820 | Disposed |
| May 20, 2026 | GYRE | Stock Option (Right to Buy) | Common Stock (9,400) | $0.75 | Oct. 31, 2030 | 9,400 | Disposed |
| May 19, 2026 | GYRE | Stock Option (Right to Buy) | Common Stock (9,120) | $0.75 | Oct. 31, 2030 | 9,120 | Disposed |
| May 18, 2026 | GYRE | Stock Option (Right to Buy) | Common Stock (200) | $0.75 | Oct. 31, 2030 | 200 | Disposed |
| May 15, 2026 | GYRE | Stock Option (Right to Buy) | Common Stock (13,100) | $0.75 | Oct. 31, 2030 | 13,100 | Disposed |
| May 14, 2026 | GYRE | Stock Option (Right to Buy) | Common Stock (15,580) | $0.75 | Oct. 31, 2030 | 15,580 | Disposed |
| April 1, 2025 | GYRE | Stock Option (Right to Buy) | Common Stock (50,000) | $0.75 | Oct. 31, 2030 | 50,000 | Disposed |
| March 27, 2025 | GYRE | Stock Option (Right to Buy) | Common Stock (150,000) | $0.75 | Oct. 31, 2030 | 150,000 | Disposed |
| March 26, 2025 | GYRE | Stock Option (Right to Buy) | Common Stock (200,000) | $0.75 | Oct. 31, 2030 | 200,000 | Disposed |
| March 24, 2025 | GYRE | Stock Option (Right to Buy) | Common Stock (300,000) | $0.75 | Oct. 31, 2030 | 300,000 | Disposed |
| March 7, 2025 | GYRE | Stock Option (Right to Buy) | Common Stock (300,000) | $10.32 | March 7, 2035 | 300,000 | Acquired |
| Nov. 20, 2023 | GYRE | Stock Option (Right to Buy) | Common Stock (1,665,115) | — | Oct. 31, 2030 | 1,665,115 | Acquired |
Exercise/conversion price is blank when not applicable (e.g. RSUs).
Compensation (DEF 14A)
Matched by name from proxy statements (DEF 14A) — verify against the filing.
GYRE
COO| Fiscal year | Salary | Bonus | Stock awards | Option awards | Non-equity incentive | Pension change | Other | Total |
|---|---|---|---|---|---|---|---|---|
| 2025 | $196,951 | — | — | $4,460,335 | $344,398 | — | $22,065 | $5,023,749 |
| 2024 | $148,279 | — | — | — | $168,499 | — | $15,841 | $332,619 |
| 2023 | $265,656 | — | — | — | — | — | $8,961 | $274,617 |
Figures from the Summary Compensation Table of the company's proxy statement (DEF 14A). Compensation is not a recommendation.